immune system
N |
• mice exhibit roughly normal humoral responses
|
• LPS-stimulated CD19+ splenocytes exhibit reduced proliferation compared with similarly treated wild-type cells
|
• BCR-cross-linking stimulated increased proliferation in CD19+ splenocytes compared with similarly treated wild-type cells
|
• mice exhibit a 3-fold reduction in bone marrow B-lineage cells compared with wild-type mice
• mice exhibit a blockage in the transition from large pre-BII (BP1+) to small pre-BII (BP1-) unlike wild-type mice
• B cells are constitutively activated and committed to CD138+ differentiation unlike in wild-type mice
|
• immunized mice exhibit increased plasma cell differentiation compared with wild-type mice
• stimulated splenocytes exhibit a bias towards plasma cell differentiation unlike wild-type cells
• however, the ratio of long-lived to short lived plasma cells is normal
|
• in the spleen
|
• mice exhibit an 8-fold reduction in the absolute value of CD25+B220+ pre-BII cells compared with wild-type mice
• mice exhibit a reduction in the proportion of CD25+VpreB- cells compared with wild-type mice
|
• mice exhibit a 3 times increase in VpreB+ cells, which include pro-B/preBI and pre-BII cells, compared with wild-type mice
• mice exhibit an increase in B220+ BCR- cells compared with wild-type mice
|
• immunized mice exhibit a 6-fold increase in plasma cells compared with wild-type mice
|
• reduced 10- to 100-fold
|
• reduced 10- to 100-fold
|
• absent
|
• Peyer's patches are reduced in number or absent unlike in wild-type mice
|
hematopoietic system
• LPS-stimulated CD19+ splenocytes exhibit reduced proliferation compared with similarly treated wild-type cells
|
• BCR-cross-linking stimulated increased proliferation in CD19+ splenocytes compared with similarly treated wild-type cells
|
• mice exhibit a 3-fold reduction in bone marrow B-lineage cells compared with wild-type mice
• mice exhibit a blockage in the transition from large pre-BII (BP1+) to small pre-BII (BP1-) unlike wild-type mice
• B cells are constitutively activated and committed to CD138+ differentiation unlike in wild-type mice
|
• immunized mice exhibit increased plasma cell differentiation compared with wild-type mice
• stimulated splenocytes exhibit a bias towards plasma cell differentiation unlike wild-type cells
• however, the ratio of long-lived to short lived plasma cells is normal
|
• in the spleen
|
• mice exhibit an 8-fold reduction in the absolute value of CD25+B220+ pre-BII cells compared with wild-type mice
• mice exhibit a reduction in the proportion of CD25+VpreB- cells compared with wild-type mice
|
• mice exhibit a 3 times increase in VpreB+ cells, which include pro-B/preBI and pre-BII cells, compared with wild-type mice
• mice exhibit an increase in B220+ BCR- cells compared with wild-type mice
|
• immunized mice exhibit a 6-fold increase in plasma cells compared with wild-type mice
|
• reduced 10- to 100-fold
|
• reduced 10- to 100-fold
|
• absent
|
cellular
• LPS-stimulated CD19+ splenocytes exhibit reduced proliferation compared with similarly treated wild-type cells
|
• BCR-cross-linking stimulated increased proliferation in CD19+ splenocytes compared with similarly treated wild-type cells
|